Orphazyme A/S: Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Orphazymes' shares
Company announcement | Orphazyme A/S |
No. 9/2017 | Ole Maaløes Vej 3 |
DK-2200 Copenhagen N | |
www.orphazyme.com | |
Company Registration No. 32266355 | |
16 November 2017 |
Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 ("Orphazyme"), hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in Orphazyme and persons closely associated with them in Orphazymes' shares in connection with the Initial Public Offering:
1 | Details of the Reporting Person / Closely Associated Person | ||
a) | Name | Georges Gemayel | |
2 | Reason for the notification | ||
a) | Position/status | Chairman of the Board of Directors | |
b) | Initial notification/Amendment | Initial notification | |
3 | Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Orphazyme A/S | |
b) | LEI code | 54930025OZD2GGSQ7L42 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code |
Shares
ISIN DK0060910917 | |
b) | Nature of the transaction | Exercise of warrants for shares | |
c) | Price(s) and volume(s) | Price (s) | Volume(s) |
1.00 | 87,758 | ||
d) |
Aggregated information
| ||
e) | Date of the transaction | 2017-11-16 09:00 UTC+1 | |
f) | Place of the transaction | Nasdaq Copenhagen A/S - XCSE |
1 | Details of the Reporting Person / Closely Associated Person | ||
a) | Name | Bo Jesper Hansen | |
2 | Reason for the notification | ||
a) | Position/status | Deputy Chairman of the Board of Directors | |
b) | Initial notification/Amendment | Initial notification | |
3 | Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Orphazyme A/S | |
b) | LEI code | 54930025OZD2GGSQ7L42 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code |
Shares
ISIN DK0060910917 | |
b) | Nature of the transaction | Exercise of warrants for shares | |
c) | Price(s) and volume(s) | Price (s) | Volume(s) |
1.00 | 29,445 | ||
d) |
Aggregated information
| ||
e) | Date of the transaction | 2017-11-16 09:00 UTC+1 | |
f) | Place of the transaction | Nasdaq Copenhagen A/S - XCSE |
1 | Details of the Reporting Person / Closely Associated Person | ||
a) | Name | Bo Jesper Hansen | |
2 | Reason for the notification | ||
a) | Position/status | Deputy Chairman of the Board of Directors | |
b) | Initial notification/Amendment | Initial notification | |
3 | Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Orphazyme A/S | |
b) | LEI code | 54930025OZD2GGSQ7L42 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code |
Shares
ISIN DK0060911055 | |
b) | Nature of the transaction | Subscription for shares | |
c) | Price(s) and volume(s) | Price (s) | Volume(s) |
80.00 | 50,000 | ||
d) |
Aggregated information
| ||
e) | Date of the transaction | 2017-11-16 09:00 UTC+1 | |
f) | Place of the transaction | Nasdaq Copenhagen A/S - XCSE |
1 | Details of the Reporting Person / Closely Associated Person | ||
a) | Name | Bohrs Tower IVS | |
2 | Reason for the notification | ||
a) | Position/status | Closely Associated Person to Martin Bonde, member of the board of directors | |
b) | Initial notification/Amendment | Initial notification | |
3 | Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Orphazyme A/S | |
b) | LEI code | 54930025OZD2GGSQ7L42 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code |
Shares
ISIN DK0060910917 | |
b) | Nature of the transaction | Exercise of warrants for shares | |
c) | Price(s) and volume(s) | Price (s) | Volume(s) |
1.00 | 42,884 | ||
d) |
Aggregated information
| ||
e) | Date of the transaction | 2017-11-16 09:00 UTC+1 | |
f) | Place of the transaction | Nasdaq Copenhagen A/S - XCSE |
1 | Details of the Reporting Person / Closely Associated Person | |||
a) | Name | Martin Bonde | ||
2 | Reason for the notification | |||
a) | Position/status | Member of the Board of Directors | ||
b) | Initial notification/Amendment | Initial notification | ||
3 | Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
a) | Name | Orphazyme A/S | ||
b) | LEI code | 54930025OZD2GGSQ7L42 | ||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
a) | Description of the financial instrument, type of instrument and identification code |
Shares
ISIN DK0060911055 | ||
b) | Nature of the transaction | Subscription for shares | ||
c) | Price(s) and volume(s) | Price (s) | Volume(s) | |
80.00 | 3,125 | |||
d) |
Aggregated information
| |||
e) | Date of the transaction | 2017-11-16 09:00 UTC+1 | ||
f) | Place of the transaction | Nasdaq Copenhagen A/S - XCSE |
1 | Details of the Reporting Person / Closely Associated Person | ||
a) | Name | Rahbek Kornum IVS | |
2 | Reason for the notification | ||
a) | Position/status | Closely Associated Person to Martin Rahbek Kornum, member of the Board of Directors (resigned 16 November 2017) | |
b) | Initial notification/Amendment | Initial notification | |
3 | Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Orphazyme A/S | |
b) | LEI code | 54930025OZD2GGSQ7L42 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code |
Shares
ISIN DK0060910917 | |
b) | Nature of the transaction | Exercise of warrants for shares | |
c) | Price(s) and volume(s) | Price (s) | Volume(s) |
1.00 | 22,726 | ||
d) |
Aggregated information
| ||
e) | Date of the transaction | 2017-11-16 09:00 UTC+1 | |
f) | Place of the transaction | Nasdaq Copenhagen A/S - XCSE |
1 | Details of the Reporting Person / Closely Associated Person | ||
a) | Name | Catherine Moukheibir | |
2 | Reason for the notification | ||
a) | Position/status | Member of the Board of Directors | |
b) | Initial notification/Amendment | Initial notification | |
3 | Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Orphazyme A/S | |
b) | LEI code | 54930025OZD2GGSQ7L42 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code |
Shares
ISIN DK0060911055 | |
b) | Nature of the transaction | Subscription for shares | |
c) | Price(s) and volume(s) | Price (s) | Volume(s) |
80.00 | 7,980 | ||
d) |
Aggregated information
| ||
e) | Date of the transaction | 2017-11-16 09:00 UTC+1 | |
f) | Place of the transaction | Nasdaq Copenhagen A/S - XCSE |
1 | Details of the Reporting Person / Closely Associated Person | ||
a) | Name | Anders Hedegaard | |
2 | Reason for the notification | ||
a) | Position/status | Member of the Board of Directors | |
b) | Initial notification/Amendment | Initial notification | |
3 | Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Orphazyme A/S | |
b) | LEI code | 54930025OZD2GGSQ7L42 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code |
Shares
ISIN DK0060911055 | |
b) | Nature of the transaction | Subscription for shares | |
c) | Price(s) and volume(s) | Price (s) | Volume(s) |
80.00 | 6,250 | ||
d) |
Aggregated information
| ||
e) | Date of the transaction | 2017-11-16 09:00 UTC+1 | |
f) |
By: Nasdaq / GlobeNewswire
- 16 Nov 2017
Return to news
Upcoming Life Sciences Events
Latest company newsThere are currently no news available for this portal |